Related Experiment Video
Updated: Oct 24, 2025
06:30
Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases
Published on: August 27, 2021
3.3K
Identification of Ubiquitin Variants That Inhibit the E2 Ubiquitin Conjugating Enzyme, Ube2k
Adam J Middleton1, Joan Teyra2, Jingyi Zhu1
1Department of Biochemistry, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.
ACS Chemical Biology
|August 16, 2021
Summary
Researchers discovered ubiquitin variants (UbVs) that inhibit the E2 enzyme Ube2k by binding to a novel site. These UbVs block ubiquitin transfer, offering a new strategy for targeting E2 enzymes in cellular processes.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Ubiquitin conjugation is vital for eukaryotic cellular processes.
- E2 enzymes, like Ube2k, are key players in ubiquitin transfer, dictating substrate fate.
- Ube2k specifically generates degradative ubiquitin chains.
Purpose of the Study:
- To identify novel inhibitors of the E2 enzyme Ube2k.
- To characterize the binding mechanism and inhibitory effects of these inhibitors.
- To explore a new potential target site on E2 enzymes.
Main Methods:
- Identification and characterization of ubiquitin variants (UbVs).
- Co-crystallization of UbVs with Ube2k to determine structural basis of binding.
- Biochemical assays to assess inhibition of ubiquitin charging and transfer.
Main Results:
- Discovery of UbVs that bind specifically to Ube2k.
- Crystal structures reveal UbV binding at a novel hydrophobic cleft, distinct from the active site.
- UbVs potently inhibit Ube2k's function by blocking ubiquitin charging and E3-ligase mediated transfer.
Conclusions:
- UbVs represent the first protein-based inhibitors of Ube2k.
- The identified hydrophobic groove is a potential target for inhibiting Ube2k and other E2 enzymes.
- These findings offer new avenues for modulating ubiquitin signaling pathways.
Related Concept Videos
02:58Regulated Protein Degradation
8.0K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.0K
02:04Covalently Linked Protein Regulators
8.0K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.0K
01:13The Proteasome
1.2K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.2K
02:18The Proteasome
9.3K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.3K
01:57Protein Complexes with Interchangeable Parts
2.7K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.7K
01:37The Unfolded Protein Response
5.5K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.5K